11 – 20 of 55
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma
(
- Contribution to journal › Article
-
Mark
Mothers, places and risk of hospitalization for childhood asthma: a nationwide study from Sweden: Epidemiology of Allergic Disease.
(
- Contribution to journal › Article
-
Mark
Airway, apoptosis, and asthma.
(
- Contribution to journal › Letter
- 2012
-
Mark
Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor.
(
- Contribution to journal › Article
- 2011
-
Mark
Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance.
(
- Contribution to journal › Article
-
Mark
Diversity of IgE-encoding transcripts in sinus mucosa of subjects diagnosed with non-allergic fungal eosinophilic sinusitis
(
- Contribution to journal › Article
- 2009
-
Mark
Roles of plasma exudation in asthma and COPD
(
- Contribution to journal › Debate/Note/Editorial
- 2007
-
Mark
Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness.
(
- Contribution to journal › Article
-
Mark
Lipopolysaccharide administration to the allergic nose contributes to lower airway inflammation.
2007) In Clinical and Experimental Allergy(
- Contribution to journal › Article
-
Mark
Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden
(
- Contribution to journal › Article